BOLT – bolt biotherapeutics, inc. (US:NASDAQ)
Stock Stats
News
Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
Form ARS Bolt Biotherapeutics, For: Dec 31
Form DEFA14A Bolt Biotherapeutics,
Form DEF 14A Bolt Biotherapeutics, For: Jun 12
Form S-8 Bolt Biotherapeutics,
Form 10-K Bolt Biotherapeutics, For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.